Technical analysis of IRIDEX Corporation (IRIX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment.
Price Performance
| 1 month | -34.74% |
| 3 months | -46.28% |
| Year-to-date | -46.75% |
| 1 year | -52.95% |
| 3 years | -71.64% |
| 5 years | -91.58% |
52-Week Range
| 52-week High | $1.65 |
| 52-week Low | $0.61 |
| Avg Volume (90d) | 69K |
Technical Indicators
| SMA 50 | $0.83 |
| SMA 200 | $1.09 |
| Beta | 0.76 |
| 30-day Volatility (annualised) | 63.5% |
| Price vs SMA 50 | -27.0% |
| Price vs SMA 200 | -44.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.05 | |
| 2025-11 | $0.96 | -8.6% |
| 2025-12 | $1.14 | +18.7% |
| 2026-01 | $1.49 | +30.7% |
| 2026-02 | $1.40 | -6.0% |
| 2026-03 | $1.01 | -27.9% |
| 2026-04 | $1.03 | +2.0% |
| 2026-05 | $1.05 | +1.9% |
| 2026-06 | $1.15 | +9.5% |
| 2026-07 | $0.82 | -28.7% |
| 2026-08 | $0.72 | -11.8% |
| 2026-09 | $0.61 | -16.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.61 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.90 |
| EV / EBITDA | -6.71 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 1.10 |
| Current Ratio | 1.82 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -1.93 |